Evidence mapPaperPMID 39482871Full record

ArticleACS applied bio materials2024

Tracking Small Extracellular Vesicles Using a Minimally Invasive PicoGreen Labeling Strategy.

Sagar Rayamajhi, Benjamin K Gibbs, Jared Sipes, Harsh B Pathak, Stefan H Bossmann, Andrew K Godwin

Abstract read
In one paragraph

Article in ACS applied bio materials, 2024. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 3 papers.

0numbers the graph read from it
0cells of the map it votes in
3citing papers in PubMed
field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

3 citing papers in PubMed.

  1. Article
  2. Review
  3. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

6 authors.

Sagar RayamajhiDepartment of Pathology and Laboratory Medicine, University of Kansas Medical Center, Kansas City, Kansas 66160, United States.ORCID 0000-0001-5420-7873
Benjamin K GibbsDepartment of Pathology and Laboratory Medicine, University of Kansas Medical Center, Kansas City, Kansas 66160, United States.ORCID 0000-0001-6238-0465
Jared SipesDepartment of Pathology and Laboratory Medicine, University of Kansas Medical Center, Kansas City, Kansas 66160, United States.ORCID 0009-0003-1065-3208
Harsh B PathakDepartment of Pathology and Laboratory Medicine, University of Kansas Medical Center, Kansas City, Kansas 66160, United States.ORCID 0000-0003-4034-0520
Stefan H BossmannDepartment of Cancer Biology, University of Kansas Medical Center, Kansas City, Kansas 66160, United States.ORCID 0000-0002-0058-0127
Andrew K GodwinDepartment of Pathology and Laboratory Medicine, University of Kansas Medical Center, Kansas City, Kansas 66160, United States.ORCID 0000-0002-3987-9580

Funding

Using Integrated Omics to Identify Dysfunctional Genetic Mechanisms Influencing Schizophrenia and Sleep DisturbancesP20GM130423 · NIGMS · UNIVERSITY OF KANSAS MEDICAL CENTER · 2022 to 2025
$6.0M
Transgenic & Gene-Targeting Shared ResourceP30CA168524 · UNIVERSITY OF KANSAS MEDICAL CENTER · 2025 to 2025
$2.8M
Extracellular Vesicle Proteomic Fingerprinting of Ovarian Cancer for Early Detection with a Nanoengineered MicrosystemR01CA260132 · UNIVERSITY OF KANSAS MEDICAL CENTER · 2025 to 2025
$910k
NCI NIH HHS P30 CA168524NCI NIH HHS R01 CA260132NICHD NIH HHS U54 HD090216NIGMS NIH HHS P20 GM130423
6 · The paper itself

Abstract

Extracellular vesicles (EVs) are cell-secreted lipid bilayer delimited particles that mediate cellular communication. These tiny sacs of cellular information play an important role in cell communication and alter the physiological process under both normal and pathological conditions. As such, tracking EVs can provide valuable information regarding the basic understanding of cell communication, the onset of early malignancy, and biomarker discovery. Most of the current EV-tracking strategies are invasive, altering the natural characteristics of EVs by modifying the lipid bilayer with lipophilic dyes or surface proteins with fluorescent reporters. The invasive labeling strategies could alter the natural processes of EVs and thereby have major limitations for functional studies. Here, we report an alternative minimally invasive EV labeling strategy using PicoGreen (PG), a small molecule that fluoresces at 520 nm when bound to dsDNA. We show that PG binds to dsDNA associated with small EVs (50-200 nm), forming a stable and highly fluorescent PG-DNA complex in EVs (PG-EVs). In both 2D cell culture and 3D organoid models, PG-EV showed efficient tracking properties, including a high signal-to-noise ratio, time- and concentration-dependent uptake, and the ability to traverse a 3D environment. We further validated PG-EV tracking using dual-labeled EVs following two orthogonal labeling strategies: (1) Bioconjugation via surface amine labeling and (2) donor cell engineering via endogenously expressing mCherry-tetraspanin (CD9/CD63/CD81) reporter proteins. Our study has shown the feasibility of using PG-EV as an effective EV tracking strategy that can be applied for studying the functional role of EVs across multiple model systems.

Indexed as

Biocompatible MaterialsExtracellular VesiclesFluorescent DyesDNAHumansMaterials TestingMolecular StructureParticle SizeBiocompatible MaterialsDNAFluorescent DyesdsDNA intercalatordual-labeled EVsEV-trackingmCherry EVsminimally invasive EV-labelingPicoGreen-based EV-labeling

Identifiers

PMID39482871
PMCPMC11577420

What Socratic holds

Textmetadata
LicenceCC BY-NC-ND
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the Socratic graph.